mcadoo3312

Biotech: The Next Big Bubble?

Even though his analysis included that fraud, the overall idea is right. I disagree with one of the commenters above that said it was not good to trade these things. Because they are so volatile and risky, I would take huge gains on a stock, even if it could go higher, because the odds of it staying that consistently high are not good.

The article was also way too general. "Having enough cash" is relative to each individual company, the strength and versitility of the drug, and the burn rate. There are tons of opportunities going into the new year because there has been such little buying of the extremely beaten down stocks which could also be exacerbated by tax loss selling. I am expecting a healthy January Effect bounce in some companies, especially those that have already received FDA approval.